GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 10 best-value penny stocks to buy, according to analysts. On June 6, the ...

Community Link allows independent pharmacies to direct contract with GoodRx, manage participation in the company’s Integrated Savings Program and other benefits. Manage Participation in GoodRx ...

For FY25, GoodRx has maintained its full-year revenue outlook at $810-$840 million, or 2-6% growth. However, it has slightly nudged up its adjusted EBITDA guidance to $273-$287 million, the ...

Niche healthcare company GoodRx Holdings (GDRX -0.61%) was looking spry and healthy on the stock market Thursday. Investors were happy to take a few doses of it following the company's release of ...

On Thursday, GoodRx (GDRX) launched a new way to pay for and get prescriptions filled that mimics the e-commerce experience. The company will eventually build it out for all its pharmacy partners.

GoodRx is a top small-cap value stock pick with strong EBITDA, new strategic leadership, and promising growth projected for FY25. Read why I'm upgrading the GDRX stock to a buy.

GoodRx is starting the new year with a lower stock price than at the outset of 2024. But in the third quarter, the company posted revenue of $195.3 million, a more than 8% increase year over year.

SANTA MONICA, Calif., January 07, 2025--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more ...

GoodRx and multiple pharmacy benefit managers (PBMs) have been hit by class action lawsuits alleging the companies conspired to fix prices that PBMs pay for prescription drug claims, therefore ...

GoodRx Holdings et al, U.S. District Court for the District of Rhode Island, No. 1:24-cv-00453. For Keaveny Drug: Heidi Silton of Lockridge Grindal Nauen, Bobby Pouya of Pearson Warshaw and others ...

GoodRx is offering 30 common heart health medications for less than $30 at more than 70,000 pharmacies across the country. Cardiovascular disease is the leading cause of death in the U.S.

GoodRx Holdings, Inc. (GDRX) shares are down more than 7% Tuesday after CVS Health (NYSE: CVS) announced a plan to deliver a more transparent and sustainable reimbursement model from pharmacy benefit ...